Insulin-induced lipohypertrophy: Report of a case with histopathology

Endocrine Journal

Volumn 52, Issue 5, 2005, Pages 623-628

  Fujikura, Junji ^a,d   Fujimoto, Muneya ^a   Yasue, Shintaro ^a   Noguchi, Michio ^a   Masuzaki, Hiroaki ^a   Hosoda, Kiminori ^a   Tachibana, Takao ^b   Sugihara, Hajime ^c   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TENRI HOSPITAL   (Japan)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^d NONE   (Japan)

Author keywords

Adipocytes; Insulin induced lipohypertrophy; Scanning electron microscopy

Indexed keywords

FAT DROPLET; RECOMBINANT HUMAN INSULIN;

ABDOMEN; ADIPOCYTE; ADIPOSE TISSUE; AGED; ANAMNESIS; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL SIZE; CLINICAL FEATURE; DERMIS; EDEMA; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHY; IN VIVO STUDY; INJECTION SITE; LIPOHYPERTROPHY; MICROSCOPY; NON INSULIN DEPENDENT DIABETES MELLITUS; SUBCUTANEOUS TISSUE;

ADIPOCYTES; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; LIPODYSTROPHY; MICROSCOPY, ELECTRON, SCANNING;

EID: 27744602303     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.52.623     Document Type: Article

References (16)

1. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS (2001) The continuing increase of diabetes in the US. Diabetes Care 24: 412.
2. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonyl-ureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853.
3. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2000) Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342: 381-389.
4. Richardson T, Kerr D (2003) Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol 4: 661-667.
5. Schiazza L, Occella C, Bleidl D, Rampini E (1990) Insulin lipohypertrophy. J Am Acad Dermatol 22: 148-149.
6. Hauner H, Stockamp B, Haastert B (1996) Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Exp Clin Endocrinol 104: 106-110.
7. Kordonouri O, Lauterborn R, Deiss D (2002) Lipohypertrophy in young patients with type 1 diabetes. Diabetes Care 25: 634.
8. Mu L, Goldman JM (2000) Human recombinant DNA insulin-induced lipoatrophy in a patient with type 2 diabetes mellitus. Endocr Pract 6: 151-152.
9. Reeves WG, Allen BR, Tattersall RB (1980) Insulin-induced lipoatrophy: evidence for an immune pathogenesis. Br Med J 280: 1500-1503.
10. Young RJ, Hannan WJ, Frier BM, Steel JM, Duncan LJ (1984) Diabetic lipohypertrophy delays insulin absorption. Diabetes Care 7: 479-480.
11. Chowdhury TA, Escudier V (2003) Poor glycaemic control caused by insulin induced lipohypertrophy. Br Med J 327: 383-384.
12. Hirsch J, Batchelor B (1976) Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 5: 299-311.
13. Russell TR, Ho R (1976) Conversion of 3T3 fibroblasts into adipose cells: triggering of differentiation by prostaglandin F2alpha and 1-methyl-3-isobutyl xanthine. Proc Natl Acad Sci USA 73: 4516-4520.
14. Geloen A, Collet AJ, Guay G, Bukowiecki LJ (1989) Insulin stimulates in vivo cell proliferation in white adipose tissue. Am J Physiol 256: C190-C196.
15. Sugihara H, Yonemitsu N, Miyabara S, Toda S (1987) Proliferation of unilocular fat cells in the primary culture. J Lipid Res 28: 1038-1045.
16. Zhang HH, Kumar S, Barnett AH, Eggo MC (2000) Ceiling culture of mature human adipocytes: use in studies of adipocyte functions. J Endocrinol 164: 119-128.